Close Menu

Fujifilm

The partners will offer drug discovery services based on human induced pluripotent stem cells and cells derived from these.

After falling for three years in a row, mergers and acquisitions in the omics space rose sharply in 2015, driven by a few billion-dollar-plus deals.

The deal was completed on May 1, following the expiration of a tender offer in which Cellular Dynamics' shareholders tendered 90 percent of the company's common stock. 

The deal marries Cellular Dynamics' human cell line manufacturing with Fujifilm's recombinant peptide cell scaffolding offerings.

The California Institute of Technology of Pasadena has received US Patent No. 8,557,199, "Self-powered microfluidic devices, methods and systems." The claimed device consists of microfluidic channels and a pressure source for pumping reagents through the channels.

The UK's Medical Research Council has been awarded US Patent No. 8,435,775, "Mutant Pfu DNA polymerase."
Phillip Holliger, Nicola Ramsay, and Ann-Sofie Jemth are named as inventors.

The University of Washington has been awarded US Patent No. 8,420,325, "Thermostable polymerases having altered fidelity and methods of identifying and using same."
Lawrence Loeb, Leroy Hood, and Motoshi Suzuki are named as inventors.

Ehime University and Otsuka Pharmaceutical have been awarded US Patent No. 8,309,702, "Primers for detecting Plasmodium."
Takafumi Tsuboi and Eun-Taek Han are named as inventors.

Fluidigm of South San Francisco, Calif., has received US Patent No. 8,282,896, "Devices and methods for holding microfluidic devices." The patent claims a carrier for holding a microfluidic device.

New Product Watch: Jun 28, 2011

Premium

Asper Biotech's Sensorineural Hearing Loss Test, Fujifilm's DMP-5005 Materials Printer, BioForce Nanosciences' ProCleaner Plus

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.